Home/Filings/4/0001140361-11-005332
4//SEC Filing

LaBella Nicholas A. Jr. 4

Accession 0001140361-11-005332

CIK 0001104506other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:13 PM ET

Size

9.5 KB

Accession

0001140361-11-005332

Insider Transaction Report

Form 4
Period: 2011-01-31
LaBella Nicholas A. Jr.
Chief Scientific Officer
Transactions
  • Award

    Stock Option - Right to Buy

    2011-01-31$0.59/sh+248,000$146,320248,000 total
    Exercise: $0.59From: 2012-01-31Exp: 2021-01-31Common Stock (248,000 underlying)
  • Award

    Restricted Stock Units

    2011-01-31+434,000682,000 total
    Common Stock (434,000 underlying)
Footnotes (3)
  • [F1]This Option shall be exercisable with respect to twenty-five percent (25%) of the shares of Common Stock subject to this Option on the first anniversary of the Date of Grant and with respect to an additional twelve and a half percent (12.5%) of the shares of Common Stock subject to this Option on the sixth month anniversary of the First Anniversary Date and each sixth month anniversary date thereafter through the fourth anniversary of the Date of Grant.
  • [F2]Pursuant to the Management Agreement these awards are subject to both time (50% of the Award) and performance-based (50% of the Award) vesting. The portion of the Award subject to time-based vesting shall vest on the 3rd anniversary of the grant date or January 31, 2014, so long as the member of management continues to be employed by the Company. The portion of the Award subject to performance-based vesting shall vest based on the date on which the Board determines that Arikace has achieved its primary endpoint in a Phase III trial, provided that the Grantee continues to be employed with the Company on such date.
  • [F3]Restricted Stock Units will be paid to the grantee in cash upon vesting, unless one of the following occurs: 1) the shareholders of the issuer approve an amendment to the issuer's Amended & Restated 2000 Stock Incentive Plan to increase the number of shares of common stock that may be issued under the plan or 2) additional shares become available to the plan through stock option expirations and/or employee terminations, in which case the grantee may receive shares of common stock in lieu of cash.

Documents

1 file

Issuer

INSMED INC

CIK 0001104506

Entity typeother

Related Parties

1
  • filerCIK 0001487698

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:13 PM ET
Size
9.5 KB